|
ATXN10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.79776202205539E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93434157580441E-12 |
| Normal-vs-Stage2 |
5.52670000000255E-05 |
| Normal-vs-Stage3 |
6.03961325396085E-14 |
| Normal-vs-Stage4 |
1.62536650805123E-12 |
| Stage1-vs-Stage2 |
2.758600E-01 |
| Stage1-vs-Stage3 |
2.216200E-01 |
| Stage1-vs-Stage4 |
3.915600E-03 |
| Stage2-vs-Stage3 |
1.057420E-01 |
| Stage2-vs-Stage4 |
9.136600E-03 |
| Stage3-vs-Stage4 |
1.356570E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
7.370500E-04 |
| Normal-vs-Asian |
2.38160047238978E-10 |
| Caucasian-vs-AfricanAmerican |
4.032800E-01 |
| Caucasian-vs-Asian |
7.828600E-01 |
| AfricanAmerican-vs-Asian |
4.098200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.78965739397563E-12 |
| Normal-vs-Female |
1.65700786425305E-12 |
| Male-vs-Female |
6.402000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.77191594730175E-13 |
| Normal-vs-Age(41-60Yrs) |
2.85327317328665E-13 |
| Normal-vs-Age(61-80Yrs) |
2.22190044141257E-10 |
| Normal-vs-Age(81-100Yrs) |
6.604700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.238000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.552000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.154000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.832600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.827800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.904000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.466620E-01 |
| Classical-VS-Follicular |
7.526600E-01 |
| Classical-VS-Other |
1.934840E-01 |
| Classical-VS-Normal |
1.63991042967382E-12 |
| Tall-VS-Follicular |
1.229230E-01 |
| Tall-VS-Other |
6.861600E-01 |
| Tall-VS-Normal |
3.73040487389176E-11 |
| Follicular-VS-Other |
3.185000E-01 |
| Follicular-VS-Normal |
2.79809999614855E-08 |
| Other-VS-Normal |
3.84709999999844E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.65043542668764E-12 |
| Normal-vs-N1 |
4.18554080283684E-14 |
| N0-vs-N1 |
1.012210E-02 |
|
|
